Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

BACKGROUND. Immunotherapy has historically been of interest in the management of metastatic renal cell cancer (mRCC) because of its relative chemoresistance and the reproducible but low incidence of spontaneous remission in metastatic disease. Recently, targeted immunotherapies in the form of checkp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Sabanathan, Dhanusha, Park, John J., Marquez, Manuel, Francisco, Louise, Byrne, Natalie, Gurney, Howard
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2017
Teme:
Genitourinary Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728040/
https://ncbi.nlm.nih.gov/pubmed/29146617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0159
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki